The post Chainlink – Will Nasdaq CME news push LINK’s price to $15 again? appeared on BitcoinEthereumNews.com. In their latest press release, Nasdaq and the CMEThe post Chainlink – Will Nasdaq CME news push LINK’s price to $15 again? appeared on BitcoinEthereumNews.com. In their latest press release, Nasdaq and the CME

Chainlink – Will Nasdaq CME news push LINK’s price to $15 again?

3 min read

In their latest press release, Nasdaq and the CME Group announced the launch of the Nasdaq CME Crypto Index. This index focuses on top digital assets such as Bitcoin, Ethereum, and Chainlink.

For LINK, this update comes at a technically delicate time. And, it could affect the altcoin’s directional move in the near future.

How to approach a key market gap

At the time of writing, the altcoin’s price was retracing into a key market imbalance zone around $13. This price level has acted as a launchpad during LINK’s previous rallies.

As the price returned to this zone, selling pressure began to show some exhaustion signs, presenting the market gap as a key imbalance zone for the anticipated reversal. In fact, buyers appeared to be testing the waters rather than rushing in.

That is not all either as momentum indicators seemed to strengthen that case as well. On the charts, the Stochastic RSI was drifting towards the oversold territory – A zone often associated with exhaustion from sellers.

In most cases, when the Stochastic RSI reaches such levels during broader market stability, reversals become increasingly likely.

Source: TradingView

On-chain metrics’ observations

Meanwhile, on-chain activity added another layer to the story.

LINK’s circulating token turnover increased by roughly 5% over the last 24 hours. Usually, a hike in circulating turnover during a retracement phase is a sign of tactical positioning among investors, rather than panic selling.

In LINK’s case, the hike in activity suggested that participants may be preparing for a directional move.

Source: Token Terminal

All about the liquidity cluster at $15

AMBCrypto’s analysis of the token’s liquidity data also pointed to a clear short-term target. LINK’s liquidity heatmaps data revealed a notable liquidity cluster worth approximately $1.32 million sitting near the $15-level.

Such clusters tend to act like price magnets. If momentum builds from the $13-zone, that liquidity zone could become the next objective.

Source: Coinglass

Here, the institutional angle cannot be brushed aside either. Nasdaq teaming up with the CME for this index launch places Chainlink right at the heart of regulated finance.

More importantly, LINK sitting in the same basket as Bitcoin and Ethereum changes the narrative. It’s no longer just another experimental altcoin. Instead, it’s starting to look like part of crypto’s core infrastructure.

Even so, the price chart still has the final say. LINK needs to stay above the daily imbalance zone to keep the reversal anticipation alive.


Final Thoughts

  • LINK has been stabilizing near $13 as institutional headlines arrived at a technically sensitive imbalance zone.
  • Significant liquidity near $15 cements it a key target if momentum confirms a reversal.
Next: Bitcoin dominance, altcoins, and the odds of THIS breakout on the charts

Source: https://ambcrypto.com/chainlink-will-nasdaq-cme-news-push-links-price-to-15-again/

Market Opportunity
EPNS Logo
EPNS Price(PUSH)
$0.01355
$0.01355$0.01355
-0.95%
USD
EPNS (PUSH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

President Donald Trump told NBC News' Tom Llamas in an interview released on Wednesday that he has no interest in actually keeping any money he wins from his lawsuit
Share
Rawstory2026/02/05 10:43
US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

The post US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike appeared on BitcoinEthereumNews.com. US President Donald Trump said that
Share
BitcoinEthereumNews2026/02/05 10:23
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11